Senior Scientific Director, Medical Affairs

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward—beyond better, into a boundless future. Join us! As Senior Scientific Director, Medical Affairs, you will serve as the senior medical and scientific leader to generate and implement Medical Affairs strategy, maintaining the highest scientific rigor, and medical compliance. You will serve as a Disease State expert as well as Medical Reviewer for MLR and Promotional review. Responsibilities: Medical Strategy & Scientific Leadership Champion development and execution of the cross-functional Integrated Medical Affairs Plan, ensuring alignment with overall asset strategy and company goals Maintain deep scientific and medical knowledge of CNS disease state including treatment landscape and clinical decision making Work with publications and Medical Education leads, setting educational areas of interest for unsolicited continuing medical education grants, omnichannel approaches, and peer-to-peer programs Proactively bring HCPs voice on cross-functional teams, to enable effective and impactful decision making Identify data gaps to be addressed through an Integrated Data Generation Plan, set areas of interest for Investigator Initiated Studies, and partner with Health Outcomes and Economic Research to prioritize areas for real-world evidence generation Provide training for internal staff on investigational and/or approved products, disease state and unmet needs Assist with data generation, data analyses and interpretation as it relates to Phase 4 studies External Engagement & Scientific Communications Medical reviewer for Medical, Legal and Regulatory Committee and the Promotional Review Committee Oversight and hands on support in generation and dissemination of clinical and non-clinical data that supports the medical strategy and results in high quality publications Develop and cultivate long-term strategic partnerships representing Definium with clinical experts, societies, collaborative groups, advocacy groups, and other external stakeholders Participate in developing and presenting medical content at congresses, symposia and advisory boards Cross-Functional Partnership & Governance Build strong, trusted partnerships across R&D, Regulatory Affairs (RA), Commercial, Legal, Market Access, patient advocacy and government affairs Ensure adherence to global Medical Affairs standards and identify Medical policies, and processes as needed Business Development & Due Diligence As needed, Provide senior medical leadership and decision support for business strategy, innovation, and new product development across the Definium Portfolio Ensuring alignment across regulatory, HEOR, commercial, and clinical priorities to support product lifecycle success Qualifications: Advanced/doctoral degree in health sc…